These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16939855)

  • 1. Oxcarbazepine therapy in very young children: a single-center clinical experience.
    Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
    Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
    Gaily E; Granström ML; Liukkonen E
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine in the treatment of early childhood epilepsy.
    Gaily E; Granström ML; Liukkonen E
    J Child Neurol; 1997 Nov; 12(8):496-8. PubMed ID: 9430314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
    Dogan EA; Usta BE; Bilgen R; Senol Y; Aktekin B
    Epilepsy Behav; 2008 Jul; 13(1):156-61. PubMed ID: 18331816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with oxcarbazepine in clinical practice.
    Passarella B; Nozzoli C
    Funct Neurol; 2005; 20(3):131-3. PubMed ID: 16324237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
    Coppola G; Franzoni E; Verrotti A; Garone C; Sarajlija J; Operto FF; Pascotto A
    Brain Dev; 2007 Jun; 29(5):281-4. PubMed ID: 17055681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures.
    Piña-Garza JE; Espinoza R; Nordli D; Bennett DA; Spirito S; Stites TE; Tang D; Sturm Y
    Neurology; 2005 Nov; 65(9):1370-5. PubMed ID: 16275822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine in infants and young children with partial seizures.
    Northam RS; Hernandez AW; Litzinger MJ; Minecan DN; Glauser TA; Mangat S; Zheng C; Souppart C; Sturm Y
    Pediatr Neurol; 2005 Nov; 33(5):337-44. PubMed ID: 16243221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice.
    Pauletto G; Bergonzi P;
    Seizure; 2006 Apr; 15(3):150-5. PubMed ID: 16439165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience.
    Bourgeois BF; D'Souza J
    Epilepsy Behav; 2005 Nov; 7(3):375-82. PubMed ID: 16176888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine: an update of its efficacy in the management of epilepsy.
    Wellington K; Goa KL
    CNS Drugs; 2001; 15(2):137-63. PubMed ID: 11460891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy.
    Vendrame M; Khurana DS; Cruz M; Melvin J; Valencia I; Legido A; Kothare SV
    Epilepsia; 2007 Nov; 48(11):2116-20. PubMed ID: 17645535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxcarbazepine, an antiepileptic agent.
    Kalis MM; Huff NA
    Clin Ther; 2001 May; 23(5):680-700; discussion 645. PubMed ID: 11394728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and tolerability of oxcarbazepine monotherapy.
    Martinez W; Ingenito A; Blakeslee M; Barkley GL; McCague K; D'Souza J
    Epilepsy Behav; 2006 Nov; 9(3):448-56. PubMed ID: 16962380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.